文献速递瓣膜外科

主动脉瓣狭窄患者机械瓣与生物瓣的比较评估

Comparative evaluation of mechanical and biological prostheses in patients with aortic stenosis.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2025-01-01

该回顾性研究纳入乌拉圭2011至2021年因重度主动脉瓣狭窄行外科主动脉瓣置换的3944例成人患者,中位随访4.5年,比较机械瓣与生物瓣的总体生存。生物瓣在男性和未使用他汀的患者中与更高死亡率相关;按年龄分层,生物瓣在60岁以下风险更高,在70-79岁组风险更低。70岁被确定为生物瓣相对生存获益显现的阈值。

要点

  • 生物瓣在男性患者中与更高死亡率相关。
  • 生物瓣在60岁以下患者中死亡风险更高。
  • 70岁是生物瓣相对生存获益显现的阈值。

核心结论

  • 生物瓣在男性患者和60岁以下年龄组中与更差生存相关。
  • 在60-69岁患者中选择瓣膜时应考虑性别和他汀使用。
  • 70岁被确定为生物瓣相对机械瓣生存获益显现的阈值。

研究设计与样本

  • 回顾性研究,纳入乌拉圭2011至2021年因重度主动脉瓣狭窄行外科主动脉瓣置换的所有成人患者。
  • 共纳入3944例患者,其中女性1708例,中位随访时间4.5年。
  • 主要结局为基于瓣膜类型的总体生存,按效应修饰因子分层;使用Cox回归校正混杂因素。

主要发现

  • 生物瓣在男性患者中与更高死亡率相关。
  • 生物瓣在未使用他汀的患者中与更高死亡率相关。
  • 按年龄分层,生物瓣在60岁以下患者中风险更高,在70-79岁组风险更低。

关键数值与推荐

  • 生物瓣在男性患者中与更高死亡率相关。
  • 生物瓣在60岁以下患者中与更高风险相关。
  • 生物瓣在70-79岁组中与更低风险相关。
  • 70岁为生物瓣相对生存获益显现的阈值。

临床怎么用

  • 在60-69岁患者中选择瓣膜时应考虑性别和他汀使用。
  • 对男性患者和60岁以下患者,应权衡生物瓣的生存劣势。
  • 70岁可作为生物瓣相对生存获益显现的参考阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The commonly accepted aortic valve prostheses have been either mechanical or biological. Each type has its advantages and disadvantages, with age being the most widely accepted variable to determine the best option. There is, however, a range between 60 and 70 years where an individualized approach is required. METHODS: This is a retrospective study. The primary outcome was overall survival based on the type of prosthesis used, stratified by effect modifiers. Association between prosthesis type and mortality rate was evaluated using the incidence rate ratio. Secondary outcomes included cardiovascular survival, postoperative mortality and complications, adjusted for age. Cox regression analysis was performed to account for confounders. Variation in the hazard ratio for death by age was explored by fitting a restricted cubic spline to the interaction between age and valve type. We included all adult patients who underwent surgical aortic valve replacement for severe stenosis in Uruguay from 2011 to 2021. A total of 3944 patients were enrolled; 1708 were females. Median follow-up time was 4.5 years. RESULTS: Bioprostheses (BP) were associated with higher mortality in males and in patients without statins. When mortality rate was stratified by age, BP were associated with a higher risk in patients younger than 60 and a lower risk in the 70-79 age group. CONCLUSIONS: BP are associated with worse survival in male patients and in the <60-year-old age group. Gender and statins should be considered when deciding the prosthesis for patients in the 60-69 age group. When the relative survival benefit of BP was analysed, 70 years was identified as the threshold at which their benefit became evident compared to mechanical prostheses.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Montero JA, Venturino F, Cubas S, et al. Comparative evaluation of mechanical and biological prostheses in patients with aortic stenosis. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 40209078. doi:10.1093/icvts/ivaf091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。